Literature DB >> 8347786

Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China.

W Zheng1, M S Linet, X O Shu, R P Pan, Y T Gao, J F Fraumeni.   

Abstract

A population-based case-control interview study of 486 adult leukemia cases and 502 healthy controls was carried out in Shanghai, People's Republic of China during 1987-89 to evaluate the etiologic role of prior medical conditions, medications, and diagnostic X-rays. Risks were examined separately for 236 cases with acute non-lymphocytic leukemia (ANLL), 79 with chronic myeloid leukemia (CML), 81 with acute lymphocytic leukemia (ALL), and 21 with chronic lymphocytic leukemia (CLL). Little difference was found between cases and controls for prior history of diabetes, hypertension, allergic conditions, most medications, and diagnostic X-rays. A few significant associations were observed for appendectomy, tuberculosis, and for several other chronic disorders with specific leukemia cell types, but the odds ratio estimates for most of these ranged from two to three and, with the exception of the two specified above, were based generally on five or fewer exposed controls. In contrast to an association with childhood leukemia in Shanghai, prior use of chloramphenicol was not linked with ANLL or other forms of adult leukemia. Further research is needed to clarify the relation of specific medical conditions and exposures with particular subtypes of leukemia, and to examine reasons for the low incidence of CLL in China and other Asian populations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347786     DOI: 10.1007/bf00051339

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  30 in total

1.  Smoking and risk of leukemia.

Authors:  L M Brown; R Gibson; A Blair; L F Burmeister; L M Schuman; K P Cantor; J F Fraumeni
Journal:  Am J Epidemiol       Date:  1992-04-01       Impact factor: 4.897

2.  Epidemiology of diseases in adult males with leukemia.

Authors:  R Gibson; S Graham; A Lilienfeld; L Schuman; M Levin; M Swanson
Journal:  J Natl Cancer Inst       Date:  1976-05       Impact factor: 13.506

Review 3.  Neoplasia in rheumatoid arthritis.

Authors:  D P Symmons
Journal:  J Rheumatol       Date:  1988-09       Impact factor: 4.666

4.  Bone marrow depression induced by chloramphenicol or phenylbutazone. Leukemia and other sequelae.

Authors:  J F Fraumeni
Journal:  JAMA       Date:  1967-09-11       Impact factor: 56.272

5.  Rheumatoid arthritis and chronic lymphatic leukaemia.

Authors:  H G Taylor; N Nixon; T P Sheeran; P T Dawes
Journal:  Clin Exp Rheumatol       Date:  1989 Sep-Oct       Impact factor: 4.473

6.  Leukaemia incidence after iodine-131 exposure.

Authors:  P Hall; J D Boice; G Berg; G Bjelkengren; U B Ericsson; A Hallquist; M Lidberg; G Lundell; A Mattsson; J Tennvall
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

7.  Isoniazid exposure in relation to cancer incidence and mortality in a cohort of tuberculosis patients.

Authors:  G R Howe; J Lindsay; E Coppock; A B Miller
Journal:  Int J Epidemiol       Date:  1979-12       Impact factor: 7.196

8.  A population-based case-control study of childhood leukemia in Shanghai.

Authors:  X O Shu; Y T Gao; L A Brinton; M S Linet; J T Tu; W Zheng; J F Fraumeni
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

9.  Breast cancer in women with scoliosis exposed to multiple diagnostic x rays.

Authors:  D A Hoffman; J E Lonstein; M M Morin; W Visscher; B S Harris; J D Boice
Journal:  J Natl Cancer Inst       Date:  1989-09-06       Impact factor: 13.506

10.  Chronic lymphocytic leukaemia: case control epidemiological study in Yorkshire.

Authors:  R A Cartwright; S M Bernard; C C Bird; C M Darwin; C O'Brien; I D Richards; B Roberts; P A McKinney
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

View more
  11 in total

Review 1.  Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Jill Koshiol; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

Review 2.  Epidemiology of MPN: what do we know?

Authors:  L A Anderson; M F McMullin
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

Review 3.  The association between atopy and childhood/adolescent leukemia: a meta-analysis.

Authors:  Amy M Linabery; Anne M Jurek; Sue Duval; Julie A Ross
Journal:  Am J Epidemiol       Date:  2010-03-12       Impact factor: 4.897

4.  Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Malin Hultcrantz; Åsa R Derolf; Ola Landgren; Lynn R Goldin
Journal:  J Clin Oncol       Date:  2011-06-20       Impact factor: 44.544

5.  Potential Correlation Between Eczema and Hematological Malignancies Risk: A Systematic Review and Meta-Analysis.

Authors:  Zuohui Liang; Jie Liu; Hongxia Jin; Yirong Teng; Shuangyan Xu; Weimin Yan; Yun Zhu
Journal:  Front Med (Lausanne)       Date:  2022-06-29

6.  Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.

Authors:  Ola Landgren; Eric A Engels; Neil E Caporaso; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Martha S Linet; Lynn R Goldin
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

7.  Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis: A Systematic Review and Meta-analysis.

Authors:  Lily Wang; Rachel Bierbrier; Aaron M Drucker; An-Wen Chan
Journal:  JAMA Dermatol       Date:  2020-02-01       Impact factor: 10.282

8.  Diagnostic radiography and adult acute myeloid leukaemia: an interview and medical chart review study.

Authors:  J M Pogoda; P W Nichols; R K Ross; D O Stram; D C Thomas; S Preston-Martin
Journal:  Br J Cancer       Date:  2011-04-26       Impact factor: 7.640

9.  Community-acquired infections and their association with myeloid malignancies.

Authors:  Glen J Titmarsh; Mary Frances McMullin; Charlene M McShane; Mike Clarke; Eric A Engels; Lesley A Anderson
Journal:  Cancer Epidemiol       Date:  2013-11-22       Impact factor: 2.984

10.  Risks of myeloid malignancies in patients with autoimmune conditions.

Authors:  L A Anderson; R M Pfeiffer; O Landgren; S Gadalla; S I Berndt; E A Engels
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.